The m.8356T>C variant in MT-TK has been reported in at least 11 individuals from two kindreds with primary mitochondrial disease. Age of onset ranged from the first decade of life to adulthood. Features seen in affected individuals include myoclonic epilepsy with ragged red fibers (MERRF), ataxia, generalized seizures, hearing loss, and lactic acidosis. Heteroplasmy levels were consistently lower in blood and higher in muscle, ranging from 43.4% to homoplasmy (PMIDs: 8069654, 1361099; PS4_supporting). Of note, there is an additional family reported in the literature that was not considered for this variant curation given the presence of another pathogenic variant, m.3243A>G. These individuals had features similar to those seen in individuals with m.8356T>C, as well as features classic for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS; PMID: 20610441). This variant segregated with disease manifestations in multiple members of one family reported (PMID: 8069654; PP1_moderate). There are no reported cases of de novo occurrences to our knowledge. The computational predictor MitoTIP suggests this variant impacts the function of this tRNA (88.8 percentile) as does HmtVar with a score of 0.75 (PP3). This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). In cybrid cell lines homoplasmic for this variant, reduced oxygen consumption was reported, supporting the functional impact of this variant (PMID: 7739567; PS3_supporting). In summary, this variant meets criteria to be classified as likely pathogenic for primary mitochondrial disease inherited in a maternal manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on March 13, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS3_supporting, PS4_supporting, PP1_moderate, PP3, PM2_supporting.